Kinetics of anti-hepatitis B surface antigen titers after hep- atitis B vaccination in patients with inflammatory bowel disease[J]. Inflamm Bowel Dis,2013,19(3):554.Gisbert JP, Villagrasa JR, Rodriguez-Nogueiras A, Chaparro M. Kinetics of anti-hepatitis B surface antigen titers after ...
The majority of clinical laboratory use the IIF assay on HEp-2 cells or HeP2000 cells which have a higher amount of Ro antigen [28]. There are however several limitations of IIF using HEp-2 cells. Variability in the substrate used, fixation process, secondary antibody used, microscopy make ...
Skip to Main content Journals & Books Help Search My accountSign in Anticlastogenic In subject area: Chemistry About this pageAdd to MendeleySet alert On this page On this page
Thermo-life PA534981 ANTIBODY FOR HEP C VIRUS NS5B EA ￥3,613.00 EA Thermo-life PA535002 CD235A/GLYCOPHORIN A ANTIBODY, FITC CONJUGATED ￥3,613.00 FITC CONJUGATED Thermo-life PA535415 ANTIBODY FOR HEP C VIRUS E1 EA ￥3,613.00 EA Thermo-life PA535430 PHOSPHO-FOXO3 PSER253 ANTIBODY EA ￥3...
In this configuration, the three CDRs of each variable domain interact to define an antigen-biding site on the surface of the VH-VL dimer. Collectively, the six CDRs confer antigen-binding specificity to the antibody. A“single-chain Fv” or “scFv” antibody fragment is a single chain Fv...
In another embodiment, antibodies of the present invention are directed against cell surface antigens expressed on target cells and/or tissues in proliferative disorders such as cancer. In one embodiment, the antibody is an IgG1 anti-Lewis Y antibody. Lewis Y is a carbohydrate antigen with the ...
(a) Single dose inhibition of hRSV infection of HEp-2 cells by analogues of CPM tested at 3.5 μg/mL (cyclopamine: 8.5 μM, jervine: 8.2 μM, tomatidine: 7.7 μM, veratrine: 5.9 μM, veratridine: 5.2 μM, protoveratrine B: 4.3 μM, imperialine: 8.1 μ...
antigen-recognition domain might have steric advantages over the larger scFv in reaching certain small or partially hidden cell surface antigens25. The smaller size of heavy-chain-only antigen-recognition domains is also an advantage for expression from gene therapy vectors, since decreasing the size...
Western blots of CD166 in control and cells with either AKT knockdown (a′), AKT overexpressed (b′), or pTEN-HA overexpressed (c′). D, PI3K/AKT did not affect YAP gene transcription. YAP mRNA was detected by qPCR in Bel-7402 and HepG2 cells treated with either DMSO or LY294002 ...
antigen-binding protein and inefficient production due to the presence of the stop codon. Expression in bacterial cells may be inhibited by improper folding of the antibody- or antigen-binding domain. The expression can be improved by alternately mutating residues on the surface of the variable/...